Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Gilead Sciences Approved to Market HCV Drug in China

publication date: Sep 25, 2017

Gilead Sciences of the US received CFDA approval for Sovaldi®, its once-daily oral treatment for chronic hepatitis C with ribavirin and/or interferon. Last year, Gilead began building a China commercial operation in Shanghai in preparation for the approval. The Shanghai office joins Gilead's regulatory team in Beijing, a chemical manufacturing outsourcing group in Shanghai, and a new manufacturing facility under construction in Hangzhou, the company's first plant outside the US. Gilead must still address the issue of Sovaldi's price in China: in the US, a three-month treatment regimen costs close to $100,000. More details....

Stock Symbol: (NSDQ: GILD)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here